Drug Profile
Fasoracetam - Avalo Therapeutics
Alternative Names: AEVI-001; Fasoracetam; LAM 105; MDGN-001; NFC 1; NS 105Latest Information Update: 30 Aug 2021
Price :
$50
*
At a glance
- Originator Nippon Shinyaku
- Developer Cerecor
- Class Antiepileptic drugs; Neuroprotectants; Nootropics; Piperidines; Small molecules
- Mechanism of Action Cholinergic receptor agonists; GABA B receptor antagonists; Metabotropic glutamate receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Attention-deficit hyperactivity disorder; Autistic disorder; Cognition disorders; DiGeorge syndrome; Major depressive disorder